ArticleJournal of the American Academy of Dermatology2020
Janus kinase inhibitors offer promise for a new era of targeted treatment for granulomatous disorders.
Article in Journal of the American Academy of Dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 16 citations in OpenAlex.
- Clinical Efficacy of Tofacitinib in Treating Granulomatous Reaction After Mesotherapy: A Case Series Analysis.Journal of cosmetic dermatology · 2026Article
- Pseudorheumatoid nodules treated with abrocitinib.JAAD case reports · 2025Article
- Effective Treatment of Recalcitrant Generalized Papular Granuloma Annulare With Upadacitinib Monotherapy: A Case Report and Literature Review.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024Review
- Seronegative cutaneous rheumatoid nodules with positive response to tofacitinib.JAAD case reports · 2024Article
- A case of generalized granuloma annulare treated with upadacitinib.JAAD case reports · 2023Article
- The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.American journal of clinical dermatology · 2022Review
- Improvement of granulomatous skin conditions with tofacitinib in three patients: A case report.SAGE open medical case reports · 2021Article
- Generalized granuloma annulare: A widespread response to limited application of compounded 2% topical tofacitinib.JAAD case reports · 2020Article
- Delayed granulomatous eruption of the nose associated with ruxolitinib.JAAD case reports · 2020Article
- Generalized granuloma annulare associated with essential thrombocythemia.Clinical case reports · 2020Article
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.